Table 1 Study assessments

Informed Consent

X

X

X

Inclusion/exclusion criteria fulfilled

X

X

X

Demographics

X

Co-morbid conditions (self-report)

X

Charlson Co-morbidity Index [29]

X

X

X

X

X

X

X

Brief psychiatric history

X

BDI-II [23]

X

X

PHQ-9 [26]

X

X

X

X

X

X

X

X

P4 Suicidality Screener [33]

X

X

X

X

Psychiatric Assessment

X

X

X

X

X

Montgomery- Asberg Depression Rating Scale [25]

X

X

X

X

Mini International Neuropsychiatric Interview [24]

X

List of medications

X

X

X

X

X

X

X

Description of dialysis treatment

X

X

X

X

X

X

X

Mid-week pre and post dialysis blood pressure

X

X

X

X

X

X

X

X

Dry weight

X

X

X

X

X

X

X

X

Adherence to dialysis treatment

X

X

X

X

X

X

X

X

Interdialytic weight gain

X

X

X

X

X

X

X

X

Urine volume per 24 h

X

Dialysis adequacy Kt/V

X

X

X

X

X

X

X

X

Dialysis time

X

X

X

X

X

X

X

X

Urea & electrolytes^a

X

X

X

X

X

X

X

X

Full blood count^b

X

X

X

X

X

X

X

X

Liver function tests^c

X

X

X

X

X

X

X

Electrocardiogram

X

X

X

X

IMP review

X

X

X

X

X

X

Drug compliance

X

X

X

X

X

X

X

Sertraline Plasma blood test

X

Baseline assessment of signs and symptoms

X

Adverse events

X

X

X

X

X

X

X

Kidney Disease QoL questionnaire [30]

X

X

X

X

Euroqol EQ 5D questionnaire [22, 31]

X

X

X

X

Clinical Global Impression Severity Scale [28]

X

X

X

X

Clinical Global Impression Improvement Scale [28]

X

X

X